Standard BioTools Inc.
LAB
Rank in Stocks
#15242
Standard BioTools Inc., together with its subsidiaries, develops, manufactures,... Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates through Proteomics and Genomics segments. Its proteomics and genomics include instruments, consumables, and assays for clinical and diagnostic uses. The company also provides SomaScan platform that enables researchers to measure proteins simultaneously and provides deep insights into biological processes and disease mechanisms; CyTOF technology platform that uses metal-tagged antibodies and time-of-flight mass spectrometry to eliminate signal interference and expand multiplexing capabilities; Hyperion, a spatial biology platform, which unlocks deeper insights into tissue organization by preserving spatial context while enabling high-dimensional molecular and proteomic analysis; and Biomark X9 system that redefines high-throughput genomics for quantitative polymerase chain reaction applications. The company sells its instruments and consumables for research use only to academic research institutions, translational research and medicine centers, cancer centers, and clinical research laboratories, as well as biopharmaceutical, biotechnology, and plant and animal research companies. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in November 2001. Standard BioTools Inc. was incorporated in 1999 and is headquartered in Boston, Massachusetts.
Share Price
$0.6942
Last synced: 2026-11-09
Market Cap
$274.01M
Change (1 day)
9.15%
Change (1 year)
-41.66%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Standard BioTools Inc. (LAB)
Category
Healthcare
EPS for Standard BioTools Inc. (LAB)
EPS as of September 2026 TTM: $-0.11
According to Standard BioTools Inc.'s latest financial reports, its current EPS (TTM) is $-0.11. At the end of 2025 the company had an EPS of $-0.20, an increase over its 2024 EPS of $-0.52.
EPS history for Standard BioTools Inc. from 2006 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.11 | -45.00% |
| 2025 | $-0.20 | -61.54% |
| 2024 | $-0.52 | -44.68% |
| 2023 | $-0.94 | -61.32% |
| 2022 | $-2.43 | 211.54% |
| 2021 | $-0.78 | 5.41% |
| 2020 | $-0.74 | -23.71% |
| 2019 | $-0.97 | -34.90% |
| 2018 | $-1.49 | -19.02% |
| 2017 | $-1.84 | -29.77% |
| 2016 | $-2.62 | 40.86% |
| 2015 | $-1.86 | -2.11% |
| 2014 | $-1.90 | 206.45% |
| 2013 | $-0.62 | -27.91% |
| 2012 | $-0.86 | -31.75% |
| 2011 | $-1.26 | 41.57% |
| 2010 | $-0.89 | -91.92% |
| 2009 | $-11.02 | -38.26% |
| 2008 | $-17.85 | 32.52% |
| 2007 | $-13.47 | 8.11% |
| 2006 | $-12.46 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $3.45 | -3,236.36% |
US
|
|
| $-0.61 | 454.55% |
US
|
|
| $-1.20 | 990.91% |
US
|
|
| $0.97 | -981.82% |
US
|
|
| $-1.04 | 845.45% |
IL
|
Questions about Standard BioTools Inc.'s earnings per share (EPS)
What is Standard BioTools Inc.'s earnings per share (EPS)?
Standard BioTools Inc.'s earnings per share (EPS) over the last twelve months is $-0.11, as of Sep 2026.
What was Standard BioTools Inc.'s earnings per share (EPS) in 2025?
In 2025, Standard BioTools Inc.'s earnings per share (EPS) was $-0.20, compared with $-0.52 in 2024.
How has Standard BioTools Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Standard BioTools Inc.'s earnings per share (EPS) was highest in 2025 ($-0.20) and lowest in 2022 ($-2.43).
How does Standard BioTools Inc.'s earnings per share (EPS) compare with similar companies?
Standard BioTools Inc.'s earnings per share (EPS) ($-0.11) is higher than that of 3 of the 5 similar companies listed above. The highest among them is Sirona Dental Systems, Inc., with $3.45.